Xu Meng

Person

San Diego, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Oral formulations and lipophilic salts of methylnaltrexone
- Patent number 10,507,206
- Issue date Dec 17, 2019
- Wyeth, LLC
- Syed M. Shah
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Oral formulations and lipophilic salts of methylnaltrexone
- Patent number 10,376,505
- Issue date Aug 13, 2019
- Wyeth, LLC
- Syed M. Shah
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Oral formulations and lipophilic salts of methylnaltrexone
- Patent number 10,307,417
- Issue date Jun 4, 2019
- Wyeth, LLC
- Syed M. Shah
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Oral formulations and lipophilic salts of methylnaltrexone
- Patent number 9,314,461
- Issue date Apr 19, 2016
- Wyeth, LLC
- Syed M. Shah
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Oral formulations and lipophilic salts of methylnal trexone
- Patent number 8,956,651
- Issue date Feb 17, 2015
- Wyeth, LLC
- Syed M. Shah
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Oral formulations and lipophilic salts of methylnaltrexone
- Patent number 8,524,276
- Issue date Sep 3, 2013
- Wyeth, LLC
- Syed M. Shah
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
ORAL FORMULATIONS AND LIPOPHILIC SALTS OF METHYLNALTREXONE
- Publication number 20200121673
- Publication date Apr 23, 2020
- Wyeth, LLC
- Syed M. SHAH
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ORAL FORMULATIONS AND LIPOPHILIC SALTS OF METHYLNALTREXONE
- Publication number 20190314365
- Publication date Oct 17, 2019
- Wyeth, LLC
- Syed M. SHAH
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ORAL FORMULATIONS AND LIPOPHILIC SALTS OF METHYLNALTREXONE
- Publication number 20190117646
- Publication date Apr 25, 2019
- Wyeth, LLC
- Syed M. SHAH
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ORAL FORMULATIONS AND LIPOPHILIC SALTS OF METHYLNALTREXONE
- Publication number 20190117645
- Publication date Apr 25, 2019
- Wyeth, LLC
- Syed M. SHAH
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ORAL FORMULATIONS AND LIPOPHILIC SALTS OF METHYLNALTREXONE
- Publication number 20160206612
- Publication date Jul 21, 2016
- Wyeth, LLC
- Syed M. Shah
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ORAL FORMULATIONS AND LIPOPHILIC SALTS OF METHYLNALTREXONE
- Publication number 20140249171
- Publication date Sep 4, 2014
- Wyeth, LLC
- Syed M. SHAH
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ORAL FORMULATIONS AND LIPOPHILIC SALTS OF METHYLNALTREXONE
- Publication number 20130330407
- Publication date Dec 12, 2013
- Wyeth, LLC
- Syed M. SHAH
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ORAL FORMULATIONS AND LIPOPHILIC SALTS OF METHYLNALTREXONE
- Publication number 20120070495
- Publication date Mar 22, 2012
- Wyeth LLC
- Syed M. SHAH
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Combination of a PTPase inhibitor and an ACE inhibitor
- Publication number 20030055058
- Publication date Mar 20, 2003
- Wyeth
- Danyi Zhang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Person

Patents Grantslast 30 patents

Oral formulations and lipophilic salts of methylnaltrexone

Oral formulations and lipophilic salts of methylnaltrexone

Oral formulations and lipophilic salts of methylnaltrexone

Oral formulations and lipophilic salts of methylnaltrexone

Oral formulations and lipophilic salts of methylnal trexone

Oral formulations and lipophilic salts of methylnaltrexone

Patents Applicationslast 30 patents

ORAL FORMULATIONS AND LIPOPHILIC SALTS OF METHYLNALTREXONE

ORAL FORMULATIONS AND LIPOPHILIC SALTS OF METHYLNALTREXONE

ORAL FORMULATIONS AND LIPOPHILIC SALTS OF METHYLNALTREXONE

ORAL FORMULATIONS AND LIPOPHILIC SALTS OF METHYLNALTREXONE

ORAL FORMULATIONS AND LIPOPHILIC SALTS OF METHYLNALTREXONE

ORAL FORMULATIONS AND LIPOPHILIC SALTS OF METHYLNALTREXONE

ORAL FORMULATIONS AND LIPOPHILIC SALTS OF METHYLNALTREXONE

ORAL FORMULATIONS AND LIPOPHILIC SALTS OF METHYLNALTREXONE

Combination of a PTPase inhibitor and an ACE inhibitor